Skip to content

Clinical trials

Phase 2 Kidney Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Neoplasms Phase: Phase 2 Country / region: France Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20031
20051
20071
20081
20093
20111
20161
20172
20182
20191
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting2
Terminated2
Active, not recruiting1
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
UNICANCER3
Centre Hospitalier Universitaire de Besancon2
Actuate Therapeutics Inc.1
Amgen1
Apollomics Inc.1
Bayer1
Bristol-Myers Squibb1
Calithera Biosciences, Inc1
Centre Oscar Lambret1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Neoplasms20
Carcinoma, Renal Cell10
Neoplasm Metastasis4
Neoplasms4
Lung Neoplasms3
Brain Neoplasms2
Breast Neoplasms2
Colonic Neoplasms2
Colorectal Neoplasms2
Lymphoma, Non-Hodgkin2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.